Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.

Journal for immunotherapy of cancer(2023)

引用 0|浏览11
暂无评分
摘要
3D measured low SFM and MBM are significant prognosis factors of NSCLC treated by immune checkpoint inhibitors and can be combined to improve the prognostic value.
更多
查看译文
关键词
subcutaneous fat,muscle masses,synergic prognostic value,3d ct,immunotherapy-treated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要